Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01472471 · ClinicalTrials.gov registry record
Urinary 8-isoprostane is Elevated in Acute Childhood Asthma
A clinical trial of Oxidative Stress and Childhood Asthma, sponsored by Stony Brook University.
- Completed
- Registry status
- 52
- Enrollment target
- 1
- Study location
NCT01472471: Completed study of Oxidative Stress and Childhood Asthma, sponsored by Stony Brook University.
NCT01472471 is a study of Oxidative Stress and Childhood Asthma that has completed, run by Stony Brook University. The registered enrollment target is 52 participants, below the 85-participant average among 36 other Oxidative Stress trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01472471, a study of Oxidative Stress and Childhood Asthma, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Oxidative stress is seen in children with asthma, but is hard to measure. The investigators exploring the utility of using a commercially available assay to measure oxidative stress in the urine in asthmatics. Additionally, the investigators will attempt to prove that oxidative stress is higher in children with acute asthma compared to those with stable asthma and that this stress is also higher in children with more severe clinical asthma exacerbations compared to less severe ones.
Conditions Studied
Study Locations (1)
New York
- Long Island Children's Hospital at Stony Brook - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-02 |
What the finished NCT01472471 record still lists
NCT01472471 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 85-participant average among 36 other Oxidative Stress trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Oxidative Stress appearing as the primary indexed condition, and to 0 interventions.
NCT01472471 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01472471 about?
NCT01472471 is a clinical study titled "Urinary 8-isoprostane is Elevated in Acute Childhood Asthma". Oxidative stress is seen in children with asthma, but is hard to measure. The investigators exploring the utility of using a commercially available assay to measure oxidative stress in the urine in asthmatics. Additionally, the investigators will attempt to prove that oxidative stress is higher in c...
What is the current status of trial NCT01472471?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2010-11. Estimated completion is 2012-02.
What conditions does trial NCT01472471 study?
This clinical trial studies the following conditions: Oxidative Stress, Childhood Asthma.
Who is sponsoring clinical trial NCT01472471?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01472471 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oxidative Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01472471's enrollment target sits among peer trials
52 16th of 36 higher than 21 of 36 other Oxidative Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oxidative Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response
RECRUITING
-
The ROAR Study: Reactive Oxygen Species and Reproduction
RECRUITING
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
RECRUITING · Phase 2
-
Impact of Haskap Berries on Recovery From High Intensity Resistance Training
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia